Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Sales | 488,032 | 453,465 | 479,928 | 461,646 | 463,312 |
| Cost of Goods | 151,230 | 139,950 | 169,810 | 135,907 | 131,455 |
| Gross Profit | 354,500 | 330,040 | 354,774 | 338,866 | 342,294 |
| Operating Expenses | 237,130 | 224,190 | 287,685 | 215,422 | 198,492 |
| Operating Income | 99,902 | 90,275 | 23,243 | 111,224 | 133,820 |
| Interest Expense | 8,190 | 6,050 | 4,672 | 2,978 | 3,353 |
| Other Income | 32,088 | 14,155 | 28,605 | 17,929 | -153,522 |
| Pre-tax Income | 123,800 | 98,380 | 47,176 | 126,175 | -23,055 |
| Income Tax | 45,060 | 31,480 | 20,880 | 37,770 | 3,841 |
| Net Income Continuous | 67,460 | 59,641 | 16,028 | 80,123 | -33,189 |
| Net Income Discontinuous | 0 | 0 | -21,080 | 0 | 0 |
| Net Income | $67,460 | $59,641 | $-5,052 | $80,123 | $-33,189 |
| EPS Basic Total Ops | 0.10 | 0.09 | 0.00 | 0.11 | -0.04 |
| EPS Basic Continuous Ops | 0.09 | 0.08 | 0.02 | 0.10 | -0.04 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.03 | N/A | N/A |
| EPS Diluted Total Ops | 0.09 | 0.08 | -0.01 | 0.10 | -0.05 |
| EPS Diluted Continuous Ops | 0.08 | 0.08 | 0.02 | 0.10 | -0.04 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.03 | N/A | N/A |
| EBITDA(a) | $99,902 | $90,275 | $109,935 | $111,224 | $133,820 |